CHIMERIC THERAPEUTICS LIMITED — Share Issue/Capital Change 2022

Mar 24, 2022

25 March 2022

ASX ANNOUNCEMENT

==> picture [262 x 53] intentionally omitted <==

Entitlement Offer Option Exercise Form

On 21 February 2022, Chimeric Therapeutics Limited (ASX:CHM) ( Chimeric or Company ) announced the details of an accelerated non-renounceable 1 for 3.15 entitlement offer ( Entitlement Offer ).

Chimeric announced the successful completion of the Institutional Entitlement Offer on 23 February 2022 and of the Retail Entitlement Offer on 23 March 2022.

New Options to be issued under the Entitlement Offer will be allotted today, and can be exercised by completing and returning the personalised Option Exercise Form that will be issued to option holders today. The New Options have an exercise price of $0.255 each, and are exercisable on or before the New Option expiry date of 31 March 2024.

Electronic access

The prospectus ( Prospectus ) under which the Entitlement Offer was made is available at www.chimerictherapeutics.com.

For further information, please contact:

If you have questions about the Entitlement Offer, please contact the share registry, Boardroom Pty Ltd on 1300 737 760 (inside Australia) or +61 2 9290 9600 (outside Australia).

On behalf of the Board

Phillip Hains Company Secretary

LEVEL 3, 62 LYGON STREET CARLTON VIC 3053 AUSTRALIA

CHIMERIC THERAPEUTICS LIMITED ACN 638 835 828

==> picture [262 x 53] intentionally omitted <==

25 March 2022

Dear Option Holder,

Entitlement Offer Option Exercise Form

You have been allocated Options under the Entitlement Offer announced by the Company on 21 February 2022.

Your enclosed option exercise form includes your personalised BPAY payment details and instructions on how to exercise your options in part or in full.

The total exercise price for the options which you chose to exercise is to be paid by BPAY or cheque, and the completed option exercise form (where applicable if opting NOT to exercise in full) can be returned to our Share Registry by mail to Chimeric Therapeutics Limited C/Boardroom Pty Limited, GPO Box 3993, SYDNEY NSW 2001.

For further instructions please see the enclosed option exercise form.

Please note that these options do not expire until 31 March 2024.

If you have any queries concerning this Notice or your option holding, please contact Share Registry, Boardroom Pty Ltd on 1300 737 760 (inside Australia) or +61 2 9290 9600 (outside Australia).

Yours faithfully

Phillip Hains Company Secretary

LEVEL 3, 62 LYGON STREET CARLTON VIC 3053 AUSTRALIA

CHIMERIC THERAPEUTICS LIMITED ACN 638 835 828

==> picture [52 x 69] intentionally omitted <==

Chimeric Therapeutics Limited ABN: 68 638 835 828

Application for Shares on Exercise of Options and Holding Statement Option exercisable at A$0.255 expiring at 5:00pm (Sydney Time) on 31 March 2024 (Options).

Please note the correct Ticker Code for the Listed Options is ASX: CHMO

HIN/SRN:

Date Options Issued: Number of Options held in your name:

To be completed by Option holder:

Number of Options being exercised: Multiplied by the Amount paid: Exercise Price of A$0.255

Payment may only be made by BPAY or cheque. Cash will not be accepted by mail or at the Chimeric Therapeutics Limited Share Registry. Payments cannot be made at any bank. Please tick the relevant box below to confirm your method of payment.

Payment option 1 – BPAY  (tick the relevant box)

==> picture [43 x 57] intentionally omitted <==

Telephone & Internet Banking - BPAY®

Biller Code: Contact your bank, credit union or building society to make this payment from your Ref: cheque or savings account.

More info: www.bpay.com.au

® Registered to BPAY Ltd ABN 69 079 137 518

• If paying by BPAY you do not need to return this Option Exercise Form. By doing so I/We agree to my/our name/s being placed on the Register of Members in respect to the number of shares in the Company allotted and to be bound by the Constitution of the Company.

• The amount of your payment received in the account divided by the Exercise Price will be deemed to be the total number of Options you are exercising. In the calculation of any entitlement, fractions will be rounded down to the nearest whole number.

Payment Option 2 – Cheque (Record cheque details below)  (tick the relevant box)

DRAWER	CHEQUE NO.	BSB NO.	ACCOUNT NO.	AMOUNT $AUD
				$

• Only cheques or bank drafts in Australian dollars and drawn on a bank or financial institution in Australia will be accepted.

• Your cheque or bank draft must be made payable to “Chimeric Therapeutics Limited ” and crossed Not Negotiable and should be attached to this form.

• The amount of your payment received in the account divided by the Exercise Price will be deemed to be the total number of Options you are exercising. In the calculation of any entitlement, fractions will be rounded down to the nearest whole number.

To the Directors of Chimeric Therapeutics Limited (‘ Company ’)

I/We being the registered holders of Options each to acquire one Fully Paid Ordinary Share in the Company hereby give notice of the exercise of Options and attach hereto my/our cheque payable to “Chimeric Therapeutics Limited” in payment of such exercise.

I/We agree to my/our name/s being placed on the Register of Members in respect to the number of shares in the Company allotted and to be bound by the Constitution of the Company.

Please sign here:

==> picture [467 x 70] intentionally omitted <==

----- Start of picture text ----- Shareholder 1 (Individual) Joint Shareholder 2 (Individual) Joint Shareholder 3 (Individual)Sole Director & Company Secretary Director Director / Company SecretaryTelephone No. (Business Hours) ( ) Date----- End of picture text -----

Lodgement of Application

Chimeric Therapeutics Limited C/- Boardroom Pty Limited, GPO Box 3993, SYDNEY NSW 2001

Neither Boardroom Pty Limited nor the Company accepts any responsibility if you lodge this Application for Shares on Exercise of Options (‘ Application Form ’) at any other address or by any other means unless paying by BPAY.